Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. by Chihana, Menard et al.
Chihana, M; Floyd, S; Molesworth, A; Crampin, AC; Kayuni, N;
Price, A; Zaba, B; Jahn, A; Mvula, H; Dube, A; Ngwira, B; Glynn,
JR; French, N (2012) Adult mortality and probable cause of death in
rural northern Malawi in the era of HIV treatment. Tropical medicine
international health , 17 (8). e74-83. ISSN 1360-2276
Downloaded from: http://researchonline.lshtm.ac.uk/230643/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial No Derivatives
http://creativecommons.org/licenses/by-nc-nd/2.5/
Adult mortality and probable cause of death in rural northern
Malawi in the era of HIV treatment
Menard Chihana1, Sian Floyd2, Anna Molesworth1,2, Amelia C. Crampin1,2, Ndoliwe Kayuni1, Alison Price1,2,
Basia Zaba2, Andreas Jahn2, Hazzie Mvula1, Albert Dube1, Bagrey Ngwira1,2, Judith R. Glynn2 and Neil French1,2
1 Karonga Prevention Study, Chilumba, Malawi
2 London School of Hygiene and Tropical Medicine, London, UK
Abstract objectives Developing countries are undergoing demographic transition with a shift from high
mortality caused by communicable diseases (CD) to lower mortality rates caused by non-communicable
diseases (NCD). HIV ⁄AIDS has disrupted this trend in sub-Saharan Africa. However, in recent years,
HIV-associated mortality has been reduced with the introduction of widely available antiretroviral
therapy (ART). Side effects of ART may lead to increased risk of cardiovascular diseases, raising the
prospects of an accelerated transition towards NCD as the primary cause of death. We report
population-based data to investigate changes in cause of death owing to NCD during the first 4 years
after introduction of HIV treatment.
methods We analysed data from a demographic surveillance system in Karonga district, Malawi, from
September 2004 to August 2009. ART was introduced in mid-2005. Clinician review of verbal autopsies
conducted 2–6 weeks after a death was used to establish a single principal cause of death.
results Over the entire period, there were 905 deaths, AIDS death rate fell from 505 to 160 ⁄100 000
person-years, and there was no evidence of an increase in NCD rates. The proportion of total deaths
attributable to AIDS fell from 42% to 17% and from NCD increased from 37% to 49%.
discussion Our findings show that 4 years after the introduction of ART into HIV care in Karonga
district, all-cause mortality has fallen dramatically, with no evidence of an increase in deaths owing to NCD.
keywords HIV, cause of death, Africa, verbal autopsy
Introduction
Many developing countries including countries in sub-
Saharan Africa are undergoing demographic transition
with a shift from high mortality caused by communicable
diseases (CD) to lower mortality rates caused by non-
communicable diseases (NCD). In 2005, it was estimated
that about 35 million people died of NCD worldwide and
around 80% of these occurred in low- and middle-income
countries (WHO ⁄World Economic Forum report 2008). It
is also predicted that by 2020, NCD will cause 70% of
all deaths in the developing world. In Africa, this transition
has been dramatically affected by HIV infection. The rise in
AIDS mortality and the re-emergence of other infectious
diseases and associated increase in mortality heightened the
concern that countries that are still in the process of
transition might be faced with a double burden of diseases,
infectious and non-infectious.
The contribution of HIV infection to mortality has been
reduced in recent years with the introduction of widely
available antiretroviral therapy (ART). In northern Malawi
(Jahn et al. 2008; Floyd et al. 2010) and elsewhere (Herbst
et al. 2009; Reniers et al. 2009; Mwagomba et al. 2010),
the population-level impacts of this intervention have been
shown to be large for both all-cause and AIDS mortality.
With decreased AIDS mortality and the disease reduced to
the level of a chronic illness by the availability of ART, a
high proportion of people will now live longer. It is thus
anticipated that there will be a shift in mortality patterns to
more deaths owing to NCD (Mayosi et al. 2009). How
quickly and how large will be the change to NCD mortality
in African countries badly affected by HIV but with falling
HIV-associated mortality is unclear. ART use is associated
with a range of side effects particularly so with the older
agents in widespread use in African treatment programmes.
Among these side effects, derangement of lipid and glucose
metabolism and impairment of renal function with conse-
quent alterations in blood pressure may create a particular
risk for cardiovascular disease (Brown et al. 2005; Mocroft
et al. 2007; Makinson et al. 2008; Crane et al. 2011).
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Malawi is one of the more severely HIV-affected African
nations with an adult HIV prevalence of around 14%, but
has also been one of the most successful in responding to
the needs for treatment. In 2004, the country introduced a
nationwide free ART treatment programme and the
country is already benefiting from the fruits of a public
health approach to ART delivery. We have been following
a rural population in Karonga district in northern Malawi
over the past 8 years and have reported the changes in
overall and HIV-associated mortality (Jahn et al. 2008;
Floyd et al. 2010). By August 2009, 4 years into the ART
programme in Karonga district, approximately 63% of the
need for ART was estimated to have been met in the local
population (Floyd et al. 2010). We now describe details
of the non-communicable causes of death to investigate
whether there is evidence of an increasing burden of NCD
during this initial period of ART introduction.
Methods
Study area
The Karonga Demographic Surveillance site (DSS) was set
up in August 2002 with a baseline census to register all
individuals and households in the study area (Jahn et al.
2007). The baseline census ended in August 2004, at that
time a continuous registration system (CRS) for demo-
graphic events has been operational in the whole of the
DSS area. Located in the southern part of Karonga district,
the DSS is between latitudes 10.38 S and 10.50 S and
longitudes 34.08 E and 34.27 E and is bordered by Lake
Malawi in the east, Nyika National Park in the south and
west, and the north demarcation follows village bound-
aries. The DSS has a population of about 33 500 individ-
uals based on 2008 mid-year population estimates, most of
whom are rural dwellers that depend on subsistence
farming and fish from the lake as a source of their
livelihood. The area has two ART clinics: Buyu, which is
70 km from the DSS, became operational in July 2005 and
Mwabi, which is located within the DSS area, became
operational in October 2006.
Data sources
A system of village key informants is used to record and
report births and deaths taking place in the area each
month, and an annual census updates household compo-
sition and migration as well as whole household change,
e.g. formation of a new household, in-migration of a whole
household from outside the DSS and movement of a whole
household within the DSS. Each key informant is respon-
sible for recording and reporting events for a single
geographically defined reporting cluster, which on average
consists of 35 households. After a key informant report, an
interviewer will visit the household to record a birth or a
death (Jahn et al. 2007). Since September 2007, HIV
testing has been offered door-to-door to all individuals
aged 15 years and older in the DSS.
When a death is reported, after allowing at least 2 weeks
of mourning, a medically trained interviewer visits the
deceased’s household to fill a semi-structured verbal
autopsy (VA) form using a method described previously
(INDEPTH Network 2003). Verbal consent is sought
before the interview. Information is gathered from a person
who was present during the deceased’s final illness or a
close relative. The completed VA forms are given to two
clinicians to review independently, each assigning a cause
of death from a pre-defined hierarchical list. For example,
if a specific condition cannot be assigned but is believed to
be communicable disease, then CD-unspecified can be
assigned. The HIV status of the deceased person, if known
from previous quality-controlled and verified karonga
prevention study (KPS) testing, is made available to
reviewers but HIV-infected individuals are not automati-
cally assumed to have died of HIV-related illnesses. If there
is a discrepancy in the diagnosis given by the two
independent reviewers, a third review is performed by
another clinician who reviews the verbal autopsy alongside
the coding and comments of the first reviews to provide a
final decision. When there is no significant pathology to
explain the cause of death, such that not even a main
grouping can be assigned, the cause of death is classified as
unknown. Deaths where no information from the VA form
was available or specific information was missing on the
form were classified as missing data.
Analysis
The analysis presented here covers the period from 1
September 2004, the date by which active vital events
reporting had been launched in the whole DSS area to
31 August 2009. Person-years of observation (PYO) were
calculated from the 1 September 2004, or the date of
migration into the DSS area if this came later, until the
earliest of date of death, out-migration from the DSS, or the
end 31 of August 2009. The person-years (time at risk) were
used as a denominator in the calculation of all mortality
rates and expressed as deaths per 100 000 PYO. Analysis
was performed using stata version 9 (StataCorp, College
Station, TX, USA), and graphs were performed in Micro-
soft Excel 2007. For analysis of all-cause mortality, all
deaths in the population are included in the numerator for
the calculation of mortality rates and individuals were
censored at the time of their death. For analysis of cause-
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specific mortality, individuals who died because of a
different or unknown cause, or with missing data on the
verbal autopsy form, were not included in the numerator
for the calculation of mortality rates, but instead were
censored from the analysis on the date they died.
Year-on-year comparison of rates, following the DSS
survey round, which starts in September and ends in
August, was used to measure trends in mortality, with
September 2004 to August 2005 as the base year. Poisson
regression was used to calculate rate ratios (RRs) for the
effect of time period, overall and stratified on age group
and sex. All-cause and category-specific mortality rates
were compared to measure the impact of ART provision on
mortality, with tests for trend using likelihood ratio tests.
The causes of death were grouped as CD, further divided
into AIDS and other CD, NCD, external causes, unknown
causes and missing data. Three age groups were considered
in the analysis – young adults 15–44 years, middle-aged
adults 45–59 years and older adults 60 or more years.
Ethical approval for the study was obtained from the
National Health Sciences Research Committee of Malawi
and the Ethics Committee of the London School of
Hygiene and Tropical Medicine.
Results
The CRS area has an adult population of 17 373 individ-
uals based on 2008 mid-year population estimates with
8124 (46.8%) males and 9249 (53.2%) females. Individ-
uals aged 15–44 years numbered 13 283, 45–59 years
2180 and 60 or more years 1910. From September 2004 to
August 2009, a total of 905 adult deaths were reported in
81 870 PYO giving a crude death rate of 1105 ⁄100 000
PYO (Table 1). For 75 deaths (8.3%), the cause was either
classified as unknown or missing data (Table 2). Of these,
16 were among 15- to 44-year olds, eight among 45- to
59-year olds and 51 among individuals aged 60 or more
years. Of all the people who died, 428 (47.3%) were males.
370 (40.9%) of the total deaths were among 15- to 44-year
olds in 62 810 PYO giving a death rate of 589 ⁄100 000
PYO (95% CI 532–652); 165 (18.2%) deaths were among
45- to 59-year olds, 10 140 PYO with a death rate of
1627 ⁄100 000 PYO (95% CI 1397–1895); and 370
(40.9%) deaths, were among individuals aged 60 or
more years old, from 8930 PYO, with a death rate
4146 ⁄100 000 PYO (95% CI 3744–4590). In summary,
all-cause mortality rate increased sharply with age group,
for 92% of deaths a cause was assigned, and most of the
deaths of unknown or un-specifiable cause were among
adults aged 60 or more years old.
Overall, CD were the largest cause of death: 419 (46%)
of the total deaths 205 (48.9%) of which were males. AIDS
was the single leading cause of death contributing 275
(65.6%) deaths to this category and (30%) overall. Pneu-
monia was the second most important cause of communi-
cable disease deaths followed by TB (Table 1). Among non-
communicable causes of death, the most common cause
was classified as gastrointestinal diseases (incorporating
peptic ulcer, liver cirrhosis and acute abdomen including
obstruction within this classification), 6.7% (n = 61). Of
the classifiable clinical syndromes, cerebrovascular disease,
congestive cardiac failure, diabetes and hypertension were
the major classified types (Table 1). Deaths owing to
external causes only contributed a small proportion to the
overall adult mortality: 47 deaths (5.2%) of which 38
(80.9% of all deaths from external clauses) were males – 28
(3.1%) were as a result of accidents whilst only 7 (0.8%)
were identified as owing to suicide.
The proportion of deaths attributed to other communi-
cable and non-communicable causes and AIDS varied by
age. Among 15- to 44-year olds, 16% of deaths were
attributed to other communicable causes, 24.3% to a non-
communicable cause and 49.2% to AIDS. The corre-
sponding figures among 45- to 59-year olds were 14.6%,
29.7% and 44.9%, and among individuals aged 60 years
or more were 16.5%, 60.8% and 5.1% (Table 4).
Mortality trends
The total mortality rate fell from 1197 ⁄100 000 PYO in
2004–05 to 944 ⁄100 000 PYO in 2008–09, a decline of
about 21% (95% CI 2–36%), P = 0.03 (Tables 2 and 3).
This fall was seen in both men and women, and the fall was
larger among individuals aged 15–59 years than among
individuals aged 60 or more years.
The AIDS mortality rate fell from 505 to 160 ⁄100 000
PYO in 2008–09, representing a 68% decrease and a rate
ratio of 0.32 (95% CI 0.20–0.50), P < 0.0001 (Tables 2
and 3). The large falls in the AIDS mortality rate were seen
in all age groups and in both men and women. Mortality
attributable to the other communicable causes of death
was higher after the baseline year, but did not rise further
over time, and there were no consistent trends in NCD
mortality rates (Table 3). The cause-specific trends in
mortality, by age group, are summarised in Figure 1. In
each age group, the only consistent trend over time was the
decrease in AIDS mortality, with some fluctuations in the
deaths attributable to NCD.
The substantial fall in AIDS mortality, with no
corresponding rise in the mortality rate of other CD or
NCD, resulted in a change in the proportion of total
deaths that were owing to each broad cause of death. In
both men and women, and all age groups, there was a
fall in the proportion of total deaths that were attributed
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to AIDS – for example from 64.6% to 30.8% among
individuals aged 15–44 years and from 60.6% to 29.2%
among individuals aged 45–59 years. The proportion of
total deaths attributed to other CD increased in both men
and women, and in all age groups and overall from
10.9% to 19.7%. The proportion of total deaths attrib-
uted to NCD increased most among adults aged 15–
59 years (Table 4).
Table 1 Probable cause of death of the 905 total adult deaths recorded in the Karonga Demographic Surveillance site during the period 1
September 2004–31 August 2009
Probable cause of death
September
4–August 5
September
5–August 6
September
6–August 7
September
7–August 8
September
8–August 9
TotalYear 1 Year 2 Year 3 Year 4 Year 5
n (%) n (%) n (%) n (%) n (%) n (%)
Communicable disease
HIV ⁄AIDS 81 (42.0) 76 (35.7) 49 (29.3) 45 (23.6) 24 (16.9) 275 (30.0)
TB or HIV ⁄AIDS 1 (0.5) 2 (0.9) 0 (0) 2 (1.1) 1 (0.7) 6 (0.7)
TB 4 (2.1) 6 (2.8) 2 (1.2) 7 (3.7) 3 (2.1) 22 (2.4)
Pneumonia 3 (1.6) 7 (3.3) 4 (2.4) 7 (3.7) 6 (4.3) 27 (3)
Hepatitis 2 (1.0) 2 (0.9) 0 (0) 0 (0) 2 (1.4) 6 (0.7)
Malaria 1 (0.5) 0 (0) 3 (1.8) 0 (0) 2 (1.4) 6 (0.7)
Meningitis 3 (1.6) 6 (2.8) 7 (4.2) 3 (1.6) 3 (2.1) 22 (2.4)
Diarrhoeal 2 (1.0) 4 (1.9) 6 (3.6) 4 (2.1) 3 (2.1) 19 (2.1)
Acute febrile disease other 3 (1.6) 5 (2.4) 11 (6.6) 4 (2.1) 8 (5.7) 31 (3.4)
Other 2 (1) 1 (0.5) 1 (0.6) 1 (0.5) 0 (0) 5 (0.6)
Total 102 (52.9) 109 (51.2) 83 (49.7) 73 (38.4) 52 (36.7) 419 (46.0)
Non-communicable diseases (NCD)
CV unspecifiable ⁄ other 1 (0.5) 0 (0) 0 (0) 3 (1.6) 1 (0.7) 5 (0.6)
Hypertension 7 (3.7) 9 (4.2) 2 (1.2) 2 (1.1) 1 (0.7) 21 (2.3)
Congestive cardiac failure 11 (5.7) 13 (6.1) 6 (3.6) 7 (3.7) 7 (4.9) 44 (4.9)
Ischaemic heart disease 1 (0.5) 0 (0) 0 (0) 1 (0.5) 0 (0) 2 (0.2)
Cerebrovascular disease 8 (4.2) 9 (4.2) 13 (7.8) 16 (8.4) 9 (6.3) 55 (6.1)
Gastrointestinal 12 (6.3) 9 (4.2) 8 (4.8) 15 (7.9) 17 (12) 61 (6.7)
Maternal 4 (2.1) 5 (2.4) 5 (3) 8 (4.2) 3 (2.1) 25 (2.8)
Cancer 10 (5.2) 8 (3.8) 8 (4.8) 13 (6.8) 9 (6.3) 48 (5.3)
Diabetes 3 (1.6) 6 (2.8) 5 (3) 3 (1.6) 9 (6.3) 26 (2.9)
Respiratory 1 (0.5) 3 (1.4) 2 (1.2) 3 (1.6) 4 (2.8) 13 (1.4)
Central nervous system 3 (1.6) 2 (0.9) 7 (4.2) 2 (1.1) 2 (1.4) 16 (1.8)
Genito-urinary 5 (2.6) 2 (0.9) 0 (0) 5 (2.6) 3 (2.1) 15 (1.7)
Anaemia 2 (1) 2 (0.9) 1 (0.6) 4 (2.1) 1 (0.7) 10 (1.1)
Nutritional 2 (1) 0 (0) 3 (1.8) 0 (0) 1 (0.7) 6 (0.7)
Other NCD 1 (0.5) 5 (2.4) 2 (1.2) 7 (3.7) 2 (1.4) 17 (1.9)
Total 71 (37) 73 (34.2) 62 (37.2) 89 (46.9) 69 (48.4) 364 (40.4)
External causes
Accidental 5 (2.6) 6 (2.8) 5 (3) 8 (4.2) 4 (2.8) 28 (3.1)
Suicide 2 (1) 0 (0) 2 (1.2) 2 (1.1) 1 (0.7) 7 (0.8)
Assault 0 (0) 1 (0.5) 0 (0) 2 (1.1) 1 (0.7) 4 (0.4)
Unknown intent ⁄ other 1 (0.5) 2 (0.9) 1 (0.6) 1 (0.5) 3 (2.1) 8 (0.9)
Total 8 (4.1) 9 (4.2) 8 (4.8) 13 (6.9) 9 (6.3) 47 (5.2)
Cause of death unknown ⁄missing data
Unknown 7 (3.7) 17 (8) 12 (7.2) 7 (3.7) 4 (2.8) 47 (5.2)
Missing data 4 (2.1) 5 (2.4) 2 (1.2) 9 (4.7) 8 (5.7) 28 (3.1)
Total 11 (5.8) 22 (10.4) 14 (8.4) 16 (8.4) 12 (8.5) 75 (8.3)
Overall total 192 (100) 213 (100) 167 (100) 191 (100) 142 (100) 905 (100)
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Discussion
During the period 2004–2009, which spanned a time of
major change in the care of HIV-infected adults in
Malawi, the all-cause mortality rate fell substantially
among adults aged 15–59 years. There was a dramatic fall
in AIDS mortality rate, with no rise in the mortality rate
owing to NCD. As expected, the major benefits in
Table 2 Mortality rates per 100 000 person-years for principal causes of death by reporting year, overall and broken by gender and
age group
Person-years of
observation
All cause AIDS
Other communicable
disease
Non-communicable
disease
n Rate (95% CI) n Rate (95% CI) n Rate (95% CI) n Rate (95% CI)
Overall
Year 1 16 050 192 1197 (1039–1378) 81 505 (406–627) 21 131 (85–201) 71 443 (351–558)
Year 2 16 650 213 1280 (1119–1464) 76 457 (365–572) 33 198 (141–279) 73 439 (349–551)
Year 3 17 020 167 981 (843–1142) 49 288 (218–381) 34 199 (143–280) 62 364 (284–467)
Year 4 17 120 191 1115 (968–1285) 45 263 (196–352) 28 163 (113–237) 89 520 (422–640)
Year 5 15 040 142 944 (801–1113) 24 160 (107–238) 28 186 (129–270) 69 459 (362–581)
Total 81 870 905 1105 (1036–1180) 275 336 (298–378) 144 176 (149–207) 364 445 (401–493)
By sex
Men
Year 1 7540 90 1194 (971–1469) 33 438 (311–616) 11 146 (81–264) 33 438 (311–616)
Year 2 7800 100 1281 (1053–1559) 35 449 (322–625) 18 231 (145–366) 30 384 (269–550)
Year 3 7970 73 916 (728–1151) 26 326 (222–479) 15 188 (113–312) 18 226 (142–358)
Year 4 8020 90 1122 (912–1379) 25 312 (211–461) 13 162 (94–279) 36 449 (324–622)
Year 5 7020 75 1068 (852–1340) 13 185 (108–319) 16 228 (140–372) 34 484 (346–678)
Total 38 360 428 1116 (1015–1227) 132 334 (290–408) 73 190 (151–239) 151 394 (336–462)
Women
Year 1 8510 102 1199 (987–1455) 48 564 (425–748) 10 118 (63–218) 38 447 (325–614)
Year 2 8840 113 1278 (1063–1537) 41 464 (341–630) 15 170 (102–281) 43 486 (261–656)
Year 3 9050 94 1039 (849–1272) 23 254 (169–383) 19 210 (134–329) 44 486 (362–654)
Year 4 9100 101 1110 (913–1349) 20 220 (142–341) 15 165 (99–273) 53 582 (445–762)
Year 5 8020 67 835 (657–1061) 11 137 (76–248) 12 150 (85–263) 35 436 (313–608)
Total 43 520 477 1096 (1002–1199) 143 329 (279–387) 71 163 (129–206) 213 490 (428–560)
By age
15–44
Year 1 12 280 82 668 (538–829) 53 432 (330–565) 8 65 (33–130) 17 139 (86–223)
Year 2 12 800 93 727 (593–890) 51 398 (303–524) 15 117 (71–194) 16 125 (77–204)
Year 3 13 120 71 541 (429–683) 32 244 (173–345) 15 114 (69–190) 19 145 (92–227)
Year 4 13 120 72 549 (436–692) 30 229 (160–327) 11 84 (46–151) 21 160 (104–246)
Year 5 11 500 52 452 (345–593) 16 139 (85–227) 10 87 (47–162) 17 148 (91–238)
Total 62 810 370 589 (532–652) 182 290 (251–335) 59 94 (73–121) 90 143 (117–176)
45–59
Year 1 2050 33 1610 (1144–2264) 20 975 (629–1500) 2 98 (24–390) 7 341 (163–716)
Year 2 2020 43 2129 (1579–2870) 21 1000 (678–1600) 8 396 (198–792) 12 594 (337–1046)
Year 3 2050 30 1466 (1025–2096) 13 635 (369–1100) 4 195 (73–521) 8 391 (195–781)
Year 4 2130 35 1646 (1182–2292) 13 611 (355–1100) 5 235 (98–565) 14 658 (390–1111)
Year 5 1900 24 1264 (847–1886) 7 369 (176–773) 5 263 (110–633) 8 421 (211–843)
Total 10 140 165 1627 (1397–1895) 74 730 (581–916) 24 237 (159–353) 49 483 (365–639)
60+
Year 1 1720 77 4485 (3588–5608) 8 466 (223–932) 11 641 (355–1157) 47 2738 (2057–3644)
Year 2 1830 77 4214 (3370–5269) 4 219 (82–583) 10 547 (294–1017) 45 2463 (1839–3298)
Year 3 1850 66 3558 (2795–4529) 4 216 (81–575) 15 809 (488–1341) 35 1887 (1355–2628)
Year 4 1880 84 4464 (847–1886) 2 106 (27–425) 12 638 (362–1123) 54 2869 (2198–3746)
Year 5 1640 66 4013 (3153–5108) 1 61 (9–431) 13 791 (459–1361) 44 2676 (1991–3595)
Total 8930 370 4146 (3744–4590) 19 213 (136–334) 61 683 (532–878) 225 2521 (2212–2873)
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reducing AIDS-related mortality were found in the
younger age groups.
Fluctuations in cause of death may be owing to
variations in verbal autopsy recording and coding (Quigley
et al. 1999, 2000; Chandramohan et al. 2001; Quigley
2005; Lopman et al. 2006, 2010), a recognised problem in
this approach. Changes in personell recording, the verbal
autopsy data and clinicians undertaking coding have
occurred during the period of this report but are unlikely to
have led to major changes in classification. However, of
particular note is that the proportion of the population
whose HIV status was known increased over the course of
the study as a consequence of house to house HIV testing
undertaken by KPS – by 2009 approximately 80% of
adults within the DSS had undergone an HIV test. These
results were made available to the coding clinicians, which
is likely to have influenced coding decisions. For instance, a
less clear diagnosis may be more likely to be classified as
Table 3 Mortality rate ratios (RR) for different causes of death, relative to the rate in Year 1 (2004–5). Broken down by gender and
age group
All cause AIDS
Other communicable
disease
Non-communicable
disease
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI)
Overall
Year 1 Reference
Year 2 1.07 (0.88–1.30) 0.90 (0.66–1.24) 1.52 (0.88–2.62) 0.99 (0.72–1.37)
Year 3 0.82 (0.67–1.01) 0.57 (0.40–0.81) 1.53 (0.89–2.63) 0.82 (0.59–1.16)
Year 4 0.93 (0.76–1.14) 0.52 (0.36–0.75) 1.25 (0.71–2.20) 1.18 (0.86–1.60)
Year 5 0.79 (0.64–0.98) 0.32 (0.20–0.50) 1.42 (0.81–2.51) 1.04 (0.74–1.44)
By sex
Men
Year 1 Reference
Year 2 1.07 (0.81–1.43) 1.02 (0.64–1.65) 1.58 (0.75–3.35) 0.88 (0.54–1.44)
Year 3 0.77 (0.56–1.04) 0.74 (0.45–1.25) 1.29 (0.59–2.81) 0.52 (0.29–0.92)
Year 4 0.94 (0.70–1.26) 0.71 (0.42–1.20) 1.11 (0.50–2.48) 1.02 (0.64–1.64)
Year 5 0.89 (0.66–1.22) 0.42 (0.22–0.80) 1.56 (0.72–3.36) 1.11 (0.68–1.79)
Women
Year 1 Reference
Year 2 1.07 (0.82–1.39) 0.82 (0.54–1.25) 1.44 (0.65–3.21) 1.09 (0.70–1.69)
Year 3 0.87 (0.66–1.15) 0.45 (0.40–0.81) 1.19 (0.83–3.84) 1.09 (0.71–1.68)
Year 4 0.93 (0.70–1.26) 0.39 (0.23–0.66) 1.40 (0.63–3.12) 1.30 (0.86–1.98)
Year 5 0.70 (0.51–0.95) 0.24 (0.13–0.47) 1.27 (0.55–2.95) 0.98 (0.62–1.55)
By age
15–44
Year 1 Reference
Year 2 1.09 (0.81–1.46) 0.92 (0.63–1.36) 1.80 (0.76–4.24) 0.90 (0.46–1.79)
Year 3 0.81 (0.59–1.11) 0.57 (0.36–0.88) 1.76 (0.74–4.14) 1.05 (0.54–2.01)
Year 4 0.82 (0.60–1.13) 0.53 (0.34–0.83) 1.29 (0.52–3.20) 1.16 (0.61–2.19)
Year 5 0.68 (0.48–0.96) 0.32 (0.18–0.56) 1.33 (0.53–3.38) 1.07 (0.55–2.09)
45–59
Year 1 Reference
Year 2 1.32 (0.84–2.08) 0.65 (0.32–1.31) 4.06 (0.86–19.12) 1.74 (0.69–4.42)
Year 3 0.91 (0.56–1.49) 0.65 (0.32–1.31) 2.00 (0.37–10.94) 1.14 (0.42–3.16)
Year 4 1.02 (0.64–1.65) 0.63 (0.31–1.26) 2.41 (0.47–12.40) 1.93 (0.78–4.78)
Year 5 0.79 (0.46–1.33) 0.38 (0.16–0.89) 2.71 (0.52–13.92) 1.23 (0.45–3.40)
60+
Year 1 Reference
Year 2 0.94 (0.69–1.29) 0.47 (0.14–1.56) 0.85 (0.36–2.01) 0.90 (0.60–1.35)
Year 3 0.79 (0.57–1.10) 0.46 (0.14–1.54) 1.26 (0.58–2.75) 0.69 (0.44–1.07)
Year 4 1.00 (0.73–1.36) 0.23 (0.05–1.07) 1.00 (0.44–2.26) 1.05 (0.71–1.55)
Year 5 0.90 (0.64–1.24) 0.13 (0.02–1.04) 1.23 (0.55–2.75) 0.98 (0.65–1.47)
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AIDS when an HIV-positive test result is available, or
excluded as AIDS when a recent HIV-negative test is
available. Although this might have affected classification
of cases of AIDS over time, it seems unlikely that this will
have affected classification of NCD deaths.
We have measured no change in mortality rates attrib-
utable to NCD. A rise in NCD deaths would have been
missed if NCD deaths were over classified in the earlier
period and ⁄or under classified in the later period. It is likely
that such misclassification would be specific to certain
clinical syndromes. For instance, an individual who dies
from a cerebrovascular accident may be difficult to
differentiate from an intra-cerebral AIDS-defining infec-
tion. Deaths as a consequence of the long-term conse-
quences of hypertension or diabetes are less likely to be
confused with HIV. The fact that no dramatic changes
occurred by individual NCD clinical syndrome over time
suggests that misclassification as a consequence of in-
creased HIV testing has not been a major problem and
supports the need to follow individual clinical syndrome
level data.
A limitation of our current approach is the coding of one
primary cause of death and not coding contributory
conditions. This is likely to compromise our ability to
identify NCD deaths in persons who are HIV infected and
thus lead to under recognition of the complications of ART
treatment. The VA tool was developed with an emphasis
on estimating the burden of deaths attributable to illnesses
for which public health interventions were available a
decade ago (Chandramohan et al. 1998). The VA has a
higher sensitivity for communicable disease conditions
than non-communicable. With the evolution in HIV care
and the conversion of this condition from a fatal to a
chronic condition, it will become increasingly important to
be able to identify the specific cause of death as it can no
longer be expected that the primary cause of death will be
an opportunistic infection and a direct consequence of
HIV. We have now moved to restructure our verbal
autopsy reporting to indicate primary and contributory
causes of death, a change that will also allow a better
understanding of the interaction between communicable
disease and NCD relevant to HIV but also to conditions
such as diabetes.
As we have shown previously, the group aged 60 or
more years was the age group least affected by the AIDS
pandemic (Floyd et al. 2010) and therefore had the least
potential to benefit from the ART treatment programme.
There was little overall change in mortality in this age
group, although most of the deaths classified as
unknown or missing data were in this age group.
Although the high rates of NCD among adults aged 60
or more years are as expected, it is also notable that this
age group has the highest rates of other CD, in
particular owing to pneumonia, diarrhoeal disease, other
acute febrile illness and tuberculosis. This is not sur-
prising as old age is a predisposing factor for these
conditions in all regions of the world. However, as the
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Figure 1 Trends in cause-specific adult mortality per 100 000
person-years, over 5 years from 2004 to 2009, broken down by
age groups (a) Age 15–44, (b) 45–59, (c) 60+ years.
Tropical Medicine and International Health volume 17 no 8 pp e74–e83 august 2012
M. Chihana et al. Effect of ART on adult mortality
e80 ª 2012 Blackwell Publishing Ltd
overall burden of death attributable to HIV declines,
control of communicable disease in the older population
represents a further target for attention in this region,
with effective preventive strategies to control tuberculo-
sis, pneumonia and influenza in particular, available for
this age group.
Table 4 Number (and percentage) of deaths attributable to each broad cause of death category among adults for each survey year overall
and broken down by gender and age group
AIDS
Other
communicable Non-communicable External
Missing ⁄
unspecified Total
Overall
Year 1 81 (42.2) 21 (10.9) 71 (37.0) 8 (4.2) 11 (5.7) 192
Year 2 76 (35.7) 33 (15.5) 73 (34.3) 8 (4.2) 22 (10.3) 213
Year 3 49 (29.3) 34 (20.4) 62 (37.1) 8 (4.8) 14 (8.4) 167
Year 4 45 (23.6) 28 (14.7) 89 (46.6) 13 (6.8) 16 (8.4) 191
Year 5 24 (16.9) 28 (19.7) 69 (48.6) 9 (6.3) 12 (8.5) 142
Total 275 (30.4) 144 (15.9) 364 (40.2) 47 (5.2) 75 (8.3) 905
By sex
Men
Year 1 33 (36.7) 11 (12.2) 33 (36.7) 7 (7.8) 6 (6.7) 90
Year 2 35 (35.0) 18 (18.0) 30 (30.0) 7 (7.0) 10 (10.0) 100
Year 3 26 (35.6) 15 (20.6) 18 (24.6) 7 (9.6) 7 (9.6) 73
Year 4 25 (27.8) 13 (14.4) 36 (40.0) 11 (12.2) 5 (5.6) 90
Year 5 13 (17.3) 16 (21.3) 34 (45.3) 6 (8.0) 6 (8.0) 75
Total 132 (30.8) 73 (17.1) 151 (35.3) 38 (8.9) 34 (7.9) 428
Women
Year 1 48 (47.1) 10 (9.8) 38 (37.3) 1 (1.0) 5 (4.9) 102
Year 2 41 (36.3) 15 (13.3) 43 (38.1) 2 (1.8) 12 (10.6) 113
Year 3 23 (24.5) 19 (20.2) 44 (46.8) 1 (1.1) 7 (7.5) 94
Year 4 20 (19.8) 15 (14.9) 53 (52.5) 2 (2.0) 11 (10.9) 101
Year 5 11 (16.2) 12 (17.9) 35 (52.2) 3 (4.5) 6 (9.0) 67
Total 143 (30.0) 71 (14.9) 213 (44.7) 9 (1.9) 41 (8.6) 477
By age
15–44
Year 1 53 (64.6) 8 (9.8) 17 (20.7) 3 (3.7) 1 (1.2) 82
Year 2 51 (54.8) 15 (16.1) 16 (17.2) 6 (6.5) 5 (5.4) 93
Year 3 32 (45.1) 15 (21.1) 19 (26.8) 3 (4.2) 2 (2.8) 71
Year 4 30 (41.7) 11 (15.3) 21 (29.2) 5 (7.0) 5 (6.9) 72
Year 5 16 (30.8) 10 (19.2) 17 (32.7) 6 (11.5) 3 (5.8) 52
Total 182 (49.2) 59 (16.0) 90 (24.3) 23 (6.2) 16 (4.3) 370
45–59
Year 1 20 (60.6) 2 (6.1) 7 (21.2) 3 (9.1) 1 (3.1) 33
Year 2 21 (48.8) 8 (18.6) 12 (27.9) 1 (2.3) 1 (2.3) 43
Year 3 13 (43.3) 4 (13.3) 8 (26.7) 2 (6.7) 3 (10.0) 30
Year 4 13 (37.1) 5 (14.3) 14 (40.0) 3 (8.6) 0 (0.0) 35
Year 5 7 (29.2) 5 (20.8) 8 (33.3) 1 (4.2) 3 (12.5) 24
Total 74 (44.9) 24 (14.6) 49 (29.7) 10 (6.1) 8 (4.9) 165
60+
Year 1 8 (10.4) 11 (14.3) 47 (61.0) 2 (2.6) 9 (11.7) 77
Year 2 4 (5.2) 10 (13.0) 45 (58.4) 2 (2.6) 16 (20.8) 77
Year 3 4 (6.1) 15 (22.7) 35 (53.0) 3 (4.6) 9 (13.6) 66
Year 4 2 (2.4) 12 (14.3) 54 (64.3) 5 (6.0) 11 (13.1) 84
Year 5 1 (1.5) 13 (19.7) 44 (66.7) 2 (3.0) 6 (9.1) 66
Total 19 (5.1) 61 (16.5) 225 (60.8) 14 (3.8) 51 (13.8) 370
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The principal causes of death in the NCD group are
consistent with findings from other developing countries,
although comparative data from countries similar to
Malawi in the south and eastern sub-Saharan African
region are scarce (Mathers et al. 2009). Diseases related
to the circulatory system, likely to be exacerbated by or
directly related to hypertension, are the most important
group. Measuring the extent of this problem and estab-
lishing measures to effectively control hypertension would
seem to be a pressing health issue for this part of the
world. Similarly, diabetes is a consistently reported
problem and may increase as a side effect of ART.
Effective methods for managing diabetes need to be
developed. As illnesses that need chronic care, it may be
possible to develop management strategies learning from
the processes developed for the assessment of and delivery
of care for HIV. Notable is the lack of deaths directly
attributable to alcohol and tobacco abuse, areas identified
for immediate action in the control of NCD (Beaglehole
et al. 2011). In the case of alcohol, deaths attributable to
its abuse may be difficult to identify in our population,
but a proportion of the deaths attributed to external
causes is highly likely to be alcohol related as well as
cases of chronic liver disease. Tobacco use is low in this
population (data not shown) and its contribution to cause
of death is likely to be small at the present time.
Free ART treatment became available to the people of
Karonga district in July 2005. At the end of this study
period, we estimated 60% of the ART treatment need,
based on the treatment criteria in effect in Malawi at that
time, was being met in Karonga district. There is no
evidence of an absolute increase in NCD mortality rates
during this initial period of ART delivery, although the
relative importance of these conditions has increased and
will necessitate action to consider how these can best be
prevented and managed in this setting. Over the longer
term, this may change, with an increasing proportion of
HIV-positive individuals on ART, on ART for a long
duration, on treatment earlier as a consequence of
changes to eligibility for ART along with broad under-
lying socio-demographic changes. It is also possible that
the AIDS mortality rate could increase again, if retention
in treatment programmes and treatment adherence are
not maintained at a high level and ⁄or drug resistance
increases. Thus, continued monitoring of cause of death
is essential and this will be best achieved through
demographic surveys whilst national civil registration
remains problematic. In addition, verbal autopsy coding
will need to adapt to ensure that primary and contrib-
utory causes of death are identified to ensure multiple
pathologies can be captured in an ageing HIV-infected
population.
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